NasdaqCM - Nasdaq Real Time Price USD

Fresh2 Group Limited (FRES)

Compare
1.3000 -0.2700 (-17.20%)
As of 2:01 PM EDT. Market Open.
Loading Chart for FRES
DELL
  • Previous Close 1.5700
  • Open 1.5100
  • Bid --
  • Ask --
  • Day's Range 1.1900 - 2.4944
  • 52 Week Range 1.1900 - 23.9500
  • Volume 1,179,573
  • Avg. Volume 7,612
  • Market Cap (intraday) 3.189M
  • Beta (5Y Monthly) 1.34
  • PE Ratio (TTM) --
  • EPS (TTM) -74.1400
  • Earnings Date Nov 5, 2024 - Nov 20, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Fresh2 Group Limited, a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the People's Republic of China. It also offers physical checkup packages, as well as technology services comprising market research, designing, coding, developing, testing, etc. In addition, the company sells genetic testing kits and skin-care products; and owns core technology platforms, as well as engages in technology development and product distribution. Further, it operates an e-commerce platform that connects food suppliers and supermarket operators and restaurant owners. The company was formerly known as AnPac Bio-Medical Science Co., Ltd. and changed its name to Fresh2 Group Limited in April 2023. The company was incorporated in 2010 and is based in New York, New York.

fresh2.co

75

Full Time Employees

December 31

Fiscal Year Ends

Recent News: FRES

View More

Performance Overview: FRES

Trailing total returns as of 9/20/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

FRES
85.39%
MSCI WORLD
15.95%

1-Year Return

FRES
92.57%
MSCI WORLD
24.51%

3-Year Return

FRES
99.82%
MSCI WORLD
0.00%

5-Year Return

FRES
99.94%
MSCI WORLD
56.87%

Compare To: FRES

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: FRES

View More

Valuation Measures

Annual
As of 9/19/2024
  • Market Cap

    3.63M

  • Enterprise Value

    3.59M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.27

  • Price/Book (mrq)

    0.28

  • Enterprise Value/Revenue

    1.50

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -61.97%

  • Return on Equity (ttm)

    -216.23%

  • Revenue (ttm)

    16.98M

  • Net Income Avi to Common (ttm)

    -136.42M

  • Diluted EPS (ttm)

    -74.1400

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    649k

  • Total Debt/Equity (mrq)

    0.18%

  • Levered Free Cash Flow (ttm)

    -39.31M

Company Insights: FRES

People Also Watch